Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Pierce
IDH1 and IDH2 Mutations in Myelodysplastic Syndromes and Role in Disease Progression
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Prognostic Interaction Between Thrombocytosis and JAK2 V617F Mutation in the WHO Subcategories of Myelodysplastic/Myeloproliferative Disease-Unclassifiable and Refractory Anemia With Ringed Sideroblasts and Marked Thrombocytosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Clinical Cancer Research
Cancer Research
Oncology
Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes
American Journal of Hematology
Hematology
IDH1 and IDH2 Mutations in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia Are Associated With a Normal Karyotype and With Der(1;7)(q10;p10)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
Cancer Informatics
Cancer Research
Oncology
Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Targeted Next-Generation Sequencing in Myelodysplastic Syndromes and Prognostic Interaction Between Mutations and IPSS-R
American Journal of Hematology
Hematology
Correction: Mutations in the DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes
Oncotarget
Oncology
Myelodysplastic Syndromes
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
